Ausgabe 1/2015
Inhalt (13 Artikel)
Pharmaceutical, Biological, and Clinical Properties of Botulinum Neurotoxin Type A Products
Jürgen Frevert
‘Similar To’ Is Not ‘Identical With’, and ‘Identical With’ Is Not ‘The Same As’
Wolfgang H. Jost
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder, Melanie J. Thomson
Efficacy of Lifestyle Changes in Subjects with Non-Alcoholic Liver Steatosis and Metabolic Syndrome May Be Improved with an Antioxidant Nutraceutical: A Controlled Clinical Study
Gianpaolo Sorrentino, Paola Crispino, Daniela Coppola, Giorgio De Stefano
mTOR: A Potential Therapeutic Target in Osteoarthritis?
Bandna Pal, Helal Endisha, Yue Zhang, Mohit Kapoor
Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature
Lael Reinstatler, Nagy A. Youssef
Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
Martino Belvederi Murri, Argentina Guaglianone, Michele Bugliani, Pietro Calcagno, Matteo Respino, Gianluca Serafini, Marco Innamorati, Maurizio Pompili, Mario Amore
Pharmacokinetics of Cefozopran by Single and Multiple Intravenous Infusions in Healthy Chinese Volunteers
G. L. Wu, J. Z. Shentu, H. L. Zhou, M. X. Zhu, X. J. Hu, J. Liu, L. H. Wu
Pharmacokinetic Effects of Simultaneous Administration of Single-Dose Gabapentin 500 mg and Zolpidem Tartrate 10 mg in Healthy Volunteers: A Randomized, Open-Label, Crossover Trial
Lawrence A. Galitz, Shyamalie Jayawardena, Sandy A. Furey
Saliva Versus Plasma Bioequivalence of Rusovastatin in Humans: Validation of Class III Drugs of the Salivary Excretion Classification System
Nasir Idkaidek, Tawfiq Arafat
Use of Adjectives in Abstracts when Reporting Results of Randomized, Controlled Trials from Industry and Academia
M. Soledad Cepeda, Jesse A. Berlin, Susan C. Glasser, Wendy P. Battisti, Martijn J. Schuemie
Effect of a Modified Saquinavir/Ritonavir Dosing Regimen with Lower Dose Lead-In Phase on QTc Interval, Pharmacokinetics, Antiviral Activity and Safety in Treatment-Naïve HIV-1-Infected Patients
Marta Boffito, Akil Jackson, Anton Pozniak, Mylene Giraudon, Rohit Kulkarni, Maria Connie Abelardo, Indravadan H. Patel, Peter N. Morcos
Budget Impact Analysis of Warfarin Reversal Therapies Among Hip Fracture Patients in Finland
Timo Purmonen, Soili Törmälehto, Niina Säävuori, Hannu Kokki